These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19484282)

  • 1. The economic burden of medical care in general and sleep apnea syndrome in particular.
    Krishnan V
    Sleep Breath; 2009 Nov; 13(4):315-6. PubMed ID: 19484282
    [No Abstract]   [Full Text] [Related]  

  • 2. The Danish study on cost effectiveness in sleep related breathing disorders - a possible example for Europe.
    Fietze I
    Thorax; 2011 Jul; 66(7):556-8. PubMed ID: 21502105
    [No Abstract]   [Full Text] [Related]  

  • 3. Elevated economic burden in obstructive lung disease patients with concomitant sleep apnea syndrome.
    Shaya FT; Lin PJ; Aljawadi MH; Scharf SM
    Sleep Breath; 2009 Nov; 13(4):317-23. PubMed ID: 19484281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic Assessment of 4 Approaches to the Diagnosis and Initial Treatment of Sleep Apnea.
    Bravata DM; Lightner N; Yaggi HK; Miech EJ
    Respir Care; 2018 Jan; 63(1):50-61. PubMed ID: 29066589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis.
    McDaid C; Griffin S; Weatherly H; Durée K; van der Burgt M; van Hout S; Akers J; Davies RJ; Sculpher M; Westwood M
    Health Technol Assess; 2009 Jan; 13(4):iii-iv, xi-xiv, 1-119, 143-274. PubMed ID: 19103134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health, social and economical consequences of sleep-disordered breathing: a controlled national study.
    Jennum P; Kjellberg J
    Thorax; 2011 Jul; 66(7):560-6. PubMed ID: 21199816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economic impact of obstructive sleep apnea.
    AlGhanim N; Comondore VR; Fleetham J; Marra CA; Ayas NT
    Lung; 2008; 186(1):7-12. PubMed ID: 18066623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of split-night polysomnography and home studies in the evaluation of obstructive sleep apnea syndrome.
    Deutsch PA; Simmons MS; Wallace JM
    J Clin Sleep Med; 2006 Apr; 2(2):145-53. PubMed ID: 17557487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health care costs and the sleep apnea syndrome.
    Wittmann V; Rodenstein DO
    Sleep Med Rev; 2004 Aug; 8(4):269-79. PubMed ID: 15233955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scoring respiratory events in sleep medicine: who is the driver--biology or medical insurance?
    Thomas RJ; Guilleminault C; Ayappa I; Rapoport DM
    J Clin Sleep Med; 2014 Nov; 10(11):1245-7. PubMed ID: 25325601
    [No Abstract]   [Full Text] [Related]  

  • 11. [Obstructive sleep apnea and arterial hypertension. How to identify candidates for the sleep laboratory].
    Sanner BM
    MMW Fortschr Med; 2004 Jun; 146(23):49-50. PubMed ID: 15373133
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical consequences and economic costs of obstructive sleep apnea syndrome].
    Xiao Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Aug; 42(8):561-563. PubMed ID: 31378015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea.
    Mar J; Rueda JR; Durán-Cantolla J; Schechter C; Chilcott J
    Eur Respir J; 2003 Mar; 21(3):515-22. PubMed ID: 12662011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CPAP reduces risk of death in people with COPD and sleep apnea.
    R I Med J (2013); 2013 Sep; 96(9):50. PubMed ID: 24960903
    [No Abstract]   [Full Text] [Related]  

  • 15. Medicaid Expansion and Mechanical Ventilation in Asthma, Chronic Obstructive Pulmonary Disease, and Heart Failure.
    Admon AJ; Sjoding MW; Lyon SM; Ayanian JZ; Iwashyna TJ; Cooke CR
    Ann Am Thorac Soc; 2019 Jul; 16(7):886-893. PubMed ID: 30811951
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cost-benefit analysis in patients with sleep-related breathing disorders - diagnosis and ncpap therapy during medical rehabilitation].
    Fischer J; Raschke F
    Biomed Tech (Berl); 2003 Sep; 48(9):245-51. PubMed ID: 14526453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cost-effectiveness analysis of automatic titration of continuous positive airway pressure at home in 1 night versus 2 nights].
    Roldán N; Sampol G; Sagalés T; Romero O; Jurado MJ; Ríos J; Lloberes P
    Arch Bronconeumol; 2008 Dec; 44(12):664-70. PubMed ID: 19091235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome: Doubled Costs Compared with Patients with Asthma Alone.
    Gerhardsson de Verdier M; Andersson M; Kern DM; Zhou S; Tunceli O
    Value Health; 2015 Sep; 18(6):759-66. PubMed ID: 26409602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive Airway Pressure Therapies and Hospitalization in Chronic Obstructive Pulmonary Disease.
    Vasquez MM; McClure LA; Sherrill DL; Patel SR; Krishnan J; Guerra S; Parthasarathy S
    Am J Med; 2017 Jul; 130(7):809-818. PubMed ID: 28089799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nasal continuous positive airway pressure therapy on health-related quality of life in sleep apnoea patients treated in the routine clinical setting of a university hospital.
    Lojander J; Räsänen P; Sintonen H; Roine RP;
    J Int Med Res; 2008; 36(4):760-70. PubMed ID: 18652772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.